hycanthone has been researched along with Precancerous Conditions in 1 studies
Hycanthone: Potentially toxic, but effective antischistosomal agent, it is a metabolite of LUCANTHONE.
hycanthone : A thioxanthen-9-one compound having a hydroxymethyl substituent at the 1-position and a 2-[(diethylamino)ethyl]amino substituent at the 4-position. It was formerly used (particularly as the monomethanesulfonic acid salt) as a schistosomicide for individual or mass treatement of infection with Schistosoma haematobium and S. mansoni, but due to its toxicity and concern about possible carcinogenicity, it has been replaced by other drugs such as praziquantel.
Precancerous Conditions: Pathological conditions that tend eventually to become malignant.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsuda, H | 1 |
| Sarma, DS | 1 |
| Rajalakshmi, S | 1 |
| Zubroff, J | 1 |
| Farber, E | 1 |
| Batzinger, RP | 1 |
| Cha, YN | 1 |
| Bueding, E | 1 |
1 other study available for hycanthone and Precancerous Conditions
| Article | Year |
|---|---|
Induction of hepatic neoplastic lesions in mice with a single dose of hycanthone methanesulfonate after partial hepatectomy.
Topics: Animals; Hepatectomy; Hycanthone; Liver Neoplasms; Liver Neoplasms, Experimental; Liver Regeneration | 1979 |